Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

<p>Abstract</p> <p>Background</p> <p>Inflammatory processes are increased in the Parkinson's disease (PD) brain. The long-term use of nonsteroidal anti-inflammatory drugs has been associated, in retrospective studies, with decreased risk for PD, suggesting that inf...

Full description

Bibliographic Details
Main Authors:	Conant Stephanie B, Camp Dianne M, Loeffler David A
Format:	Article
Language:	English
Published:	BMC 2006-10-01
Series:	Journal of Neuroinflammation
Online Access:	http://www.jneuroinflammation.com/content/3/1/29

Similar Items

Echogenicity of the substantia nigra region in Parkinson's disease
by: Edson Bor-Seng-Shu, et al.
Published: (2012-02-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
by: O.N. Voskresenskaya, et al.
Published: (2009-06-01)

Proteome analysis of human substantia nigra in Parkinson's disease
by: Werner Cornelius J, et al.
Published: (2008-02-01)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
by: T. N. Seyfried, et al.
Published: (2018-06-01)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
by: Christian Dölle, et al.
Published: (2016-11-01)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
by: Paola Feraco, et al.
Published: (2021-06-01)

In situ hybridization studies of human substantia nigra : pathophysiology of Parkinson's disease
by: Kingsbury, Ann Elizabeth
Published: (2002)

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
by: Renee M. Miller, et al.
Published: (2006-02-01)

Proliferation of Inhibitory Input to the Substantia Nigra in Experimental Parkinsonism
by: Anna Faynveitz, et al.
Published: (2019-09-01)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
by: Stefania Romeo, et al.
Published: (2014-01-01)

Diagnostic value of combined assessment of olfaction and substantia nigra hyperechogenicity for Parkinson's disease
by: N. López Hernández, et al.
Published: (2015-10-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2020-08-01)

The microcircuitry of the substantia nigra
by: Boyes, Justin
Published: (2004)

Motor Sequence Learning Deficits in Idiopathic Parkinson’s Disease Are Associated With Increased Substantia Nigra Activity
by: Elinor Tzvi, et al.
Published: (2021-06-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)

Irisin protect the Dopaminergic neurons of the Substantia nigra in the rat model of Parkinson’s disease
by: Sam Zarbakhsh, et al.
Published: (2019-07-01)

Anti-apoptotic effect of Shudipingchan granule in the substantia nigra of rat models of Parkinson′s disease
by: Qing Ye, et al.
Published: (2016-01-01)

Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia
by: Zhi-Fen Dong, et al.
Published: (2017-01-01)

Magnetic resonance spectroscopy imaging of medulla oblongata and substantia nigra in idiopathic Parkinson's disease
by: Netra Rana
Published: (2013-06-01)

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
by: Jay S Schneider
Published: (2018-01-01)

Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease
by: Rezzak Yilmaz, et al.
Published: (2016-11-01)

The Effects of Enriched Environment on Substantia nigra Tissue in Parkinson’s Disease Rats with Prenatal Stress
by: Toraj Mohammad zamani, et al.
Published: (2019-01-01)

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson’s Disease Patients
by: U. Hidding, et al.
Published: (2017-01-01)

Bidirectional modulation of substantia nigra activity by motivational state.
by: Mark A Rossi, et al.
Published: (2013-01-01)

Hyperechogenicity of the Substantia Nigra in Parkinson’s Disease: Insights from Two Brothers with Markedly Different Disease Durations
by: Julie M. Hall, et al.
Published: (2017-01-01)

Plaque complement activation and cognitive loss in Alzheimer's disease
by: Camp Dianne M, et al.
Published: (2008-03-01)

Regional High Iron in the Substantia Nigra Differentiates Parkinson’s Disease Patients From Healthy Controls
by: Kiarash Ghassaban, et al.
Published: (2019-05-01)

Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model
by: Dongsoo Kim, et al.
Published: (2018-10-01)

Pharmacocorrection of mitochondrial dysfunction and energy imbalance of substantia nigra neurons in experimental Parkinson's disease in rats
by: Volodymyr Maramukha
Published: (2020-11-01)

Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states
by: C.J. Lobb, et al.
Published: (2015-03-01)

The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
by: Elizabeth B. Moloney, et al.
Published: (2018-12-01)

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.
by: Anke A Dijkstra, et al.
Published: (2015-01-01)

An electrophysiological study of neurochemical interactions in the substantia nigra
by: Last, A. T. J.
Published: (1987)

Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
by: Kyle Farmer, et al.
Published: (2015-08-01)

Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.
by: Adriane Gröger, et al.
Published: (2014-01-01)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
by: Sarah Plum, et al.
Published: (2020-12-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson’s Disease Data
by: Elisa Mariani, et al.
Published: (2018-05-01)

Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease
by: Yuan Fang, et al.
Published: (2017-07-01)

Substantia Nigra Radiomics Feature Extraction of Parkinson’s Disease Based on Magnitude Images of Susceptibility-Weighted Imaging
by: Qingguo Ren, et al.
Published: (2021-05-01)